FORFOUNTI
"FORFOUNTI" is a word mark owned by Eli Lilly and Company, filed at the CIPO on June 26, 2025. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).
- Status
- Filed
- Since March 23, 2026
- Filed
- June 26, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 2407982
- Registration no.
- Not yet
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 1 class
Who owns FORFOUNTI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Eli Lilly and Company
LLY · United States
Representative
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
What the mark covers
The products and services FORFOUNTI is filed for, grouped by Nice class.
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone diseases and for the treatment of the musculoskeletal system, namely, connective tissue diseases and osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries, cancer, cardiovascular diseases, the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy and Parkinson's diseases, and for brain, movement, ocular motility and spinal cord diseases, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, namely, growth and thyroid disorders, diabetes, and obesity, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental health disorders, metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological diseases, namely, brain injury, spinal cord injury, seizure disorders, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases, hearing loss, obstructive sleep apnea, and peripheral arterial disease.
What has happened so far
Steps recorded by the CIPO, newest first.
- Examiner's First Report
- Search Recorded
- Pre-Assessment Letter Sent; Acceptable Goods or Services
- Formalized
- Created
- Filed
About FORFOUNTI
Who owns the trademark "FORFOUNTI"?
The CIPO trademark "FORFOUNTI" (application 2407982) is owned by Eli Lilly and Company.
What is the status of "FORFOUNTI"?
Its status at the CIPO is: filed.
Get this data via the API
Everything on this page comes from the Signa API. Pull FORFOUNTI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019ded87-7a87-7493-8ef2-f7e1609d5c3a
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019ded87-7a87-7493-8ef2-f7e1609d5c3a",
"object": "trademark",
"mark_text": "FORFOUNTI",
"status": {
"primary": "pending",
"stage": "filed"
},
"office_code": "CA",
"application_number": "2407982",
"filing_date": "2025-06-26",
"nice_classes": [
5
],
"owners": [
{
"name": "Eli Lilly and Company",
"entity_id": "ent_019f286c-97ee-774b-84b5-7d5dc09e0b99"
}
]
}